Evidence map›Paper›PMID 26742691›Full record

Observational studyNature communications2016

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination.

Slim Fourati, Razvan Cristescu, Andrey Loboda, Aarthi Talla, Ali Filali, Radha Railkar, Andrea K Schaeffer, David Favre, Dominic Gagnon, Yoav Peretz and 5 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03458780 (Single Cell Transcriptomics for Characterizing the Human Immune Response to Yellow Fever Vaccination), which is not on this map. Cited by 126 papers.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03458780 completednot on this map

Single Cell Transcriptomics for Characterizing the Human Immune Response to Yellow Fever Vaccination

TypeobservationalSponsorRockefeller UniversityRan2016 to 2018Enrolled6ConditionsHealthyArmsYellow Fever Vaccine
3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 195 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Distinct Helper T Cell Type 1 and 2 Responses Associated With Malaria Protection and Risk in RTS,S/AS01E Vaccinees.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Antiviral CD4Communications medicine · 2026
    Article
  11. Article
  12. Article
  13. Immunosenescence and susceptibility to respiratory viruses: a state-of-the-art review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Slim FouratiVaccine and Gene Therapy Institute of Florida, Port St Lucie, Florida 34987, USA.ORCID http://orcid.org/0000-0001-6609-7587
Razvan CristescuDepartment of Discovery Medicine, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Andrey LobodaDepartment of Discovery Medicine, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Aarthi TallaVaccine and Gene Therapy Institute of Florida, Port St Lucie, Florida 34987, USA.
Ali FilaliVaccine and Gene Therapy Institute of Florida, Port St Lucie, Florida 34987, USA.
Radha RailkarDepartment of Discovery Medicine, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Andrea K SchaefferDepartment of Discovery Medicine, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
David FavreCaprion/ImmuneCarta, Montréal, Québec, Canada H1W 4A4.
Dominic GagnonCaprion/ImmuneCarta, Montréal, Québec, Canada H1W 4A4.
Yoav PeretzCaprion/ImmuneCarta, Montréal, Québec, Canada H1W 4A4.
I-Ming WangDepartment of Discovery Medicine, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Chan R BealsDepartment of Discovery Medicine, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Danilo R CasimiroDepartment of Discovery Medicine, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Leonidas N CarayannopoulosDepartment of Discovery Medicine, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Rafick-Pierre SékalyVaccine and Gene Therapy Institute of Florida, Port St Lucie, Florida 34987, USA.
Merck & Co., Inc., Rahway, NJ, USA (United States) · USCornell University · USCaprion (Canada) · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is associated with hyporesponse to vaccination, whose mechanisms remain unclear. In this study hepatitis B virus (HBV)-naive older adults received three vaccines, including one against HBV. Here we show, using transcriptional and cytometric profiling of whole blood collected before vaccination, that heightened expression of genes that augment B-cell responses and higher memory B-cell frequencies correlate with stronger responses to HBV vaccine. In contrast, higher levels of inflammatory response transcripts and increased frequencies of pro-inflammatory innate cells correlate with weaker responses to this vaccine. Increased numbers of erythrocytes and the haem-induced response also correlate with poor response to the HBV vaccine. A transcriptomics-based pre-vaccination predictor of response to HBV vaccine is built and validated in distinct sets of older adults. This moderately accurate (area under the curve≈65%) but robust signature is supported by flow cytometry and cytokine profiling. This study is the first that identifies baseline predictors and mechanisms of response to the HBV vaccine.

Indexed as

AdultAgedAged, 80 and overAgingBiomarkersB-LymphocytesCohort StudiesErythrocyte CountFemaleFlow CytometryHepatitis B Surface AntigensHepatitis B VaccinesHumansInflammationMaleMiddle AgedBiomarkersHepatitis B Surface AntigensHepatitis B Vaccines

Identifiers

PMID26742691
PMCPMC4729923
OpenAlexW2229921221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.